4//SEC Filing
Mohsen Paulash 4
Accession 0000899243-22-005006
CIK 0001445283other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:05 PM ET
Size
5.8 KB
Accession
0000899243-22-005006
Insider Transaction Report
Form 4
Mohsen Paulash
Chief Business Officer
Transactions
- Sale
Common Stock
2022-02-03$1.83/sh−1,958$3,583→ 59,135 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.77 to $1.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
Documents
Issuer
YUMANITY THERAPEUTICS, INC.
CIK 0001445283
Entity typeother
Related Parties
1- filerCIK 0001834063
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:05 PM ET
- Size
- 5.8 KB